• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Communication Services·HAO
Share

Haoxi Health Technology Limited Stocks

$ 2.11Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 738990

$ 2.11
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the healthcare industry. The company was founded in 2018 and is headquartered in Beijing, China.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is undervalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 15:56

After the elections, French markets face a more serious test—the City. What should investors do?

19.10.2026 15:19

An analyst has identified a new driver for Victoria's Secret's stock: weight-loss products

19.10.2026 14:45

Fears surrounding AI are bringing treasury back into a defensive role. What should investors be prepared for?

19.10.2026 14:11

Musk promised to give SpaceX stock to “every child in America”

19.10.2026 13:25

Burry Compared the Next Crash to a Supervolcano Eruption: 5 Signs for Investors

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026